Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Sales | 31 | 187 | 422 | 786 | 0 |
| Cost of Goods | N/A | N/A | 420 | 810 | N/A |
| Gross Profit | 31 | 187 | 3 | -24 | N/A |
| Operating Expenses | 7,707 | 8,041 | 6,525 | 5,445 | 0 |
| Operating Income | -7,675 | -7,855 | -6,103 | -4,659 | N/A |
| Interest Expense | -50 | 298 | 210 | 58 | 0 |
| Other Income | 0 | -4,890 | -1,479 | -871 | 0 |
| Pre-tax Income | -7,625 | -13,043 | -7,792 | -5,588 | 0 |
| Net Income Continuous | -7,625 | -13,043 | -7,792 | -5,588 | N/A |
| Net Income Discontinuous | N/A | N/A | N/A | 2,201 | N/A |
| Net Income | $-7,625 | $-13,043 | $-7,792 | $-3,388 | $N/A |
| EPS Basic Total Ops | -12.10 | -43.75 | -33.75 | -15.50 | N/A |
| EPS Basic Continuous Ops | -12.10 | -34.83 | -31.79 | -24.50 | N/A |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 9.00 | N/A |
| EPS Diluted Total Ops | -12.10 | -43.75 | -33.75 | -15.50 | N/A |
| EPS Diluted Continuous Ops | -12.10 | -34.83 | -31.79 | -24.50 | N/A |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 9.00 | N/A |
| EPS Diluted Before Non-Recurring Items | -12.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-7,279 | $-1,159 | $-4,254 | $-4,508 | $N/A |